Physician profile
Jonathan Yang
NPI 1356879860
$1,435.00
in general payments reported to CMS, 2019-2025
8 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $81.54 · 2024: $643 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.62 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $908.07 | 2023-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $169.73 | 2024-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $105.89 | 2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals Lp | $91.49 | 2024-2025 | Airsupra, Breztri |
| Genzyme Corporation | $63.09 | 2025 | |
| Abiomed | $43.22 | 2023 | Impella |
| Philips North America LLC | $29.61 | 2024 | (8874) Incourage |
| Baxter Healthcare | $23.90 | 2024 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.